Texas Board of Pharmacy adopts stricter sterile‑compounding standards after debate over batch size, testing and costs

The Texas State Board of Pharmacy on Feb. 12 adopted a package of amendments to state sterile compounding rules that change definitions, operational standards, batch‑size limits and sterility testing requirements for compounding pharmacies.

Board members approved the final rules after staff summarized provisions that replace ‘risk‑level’ language with category‑based standards, set a default maximum batch yield of 250 final units with an exception allowing up to 1,000 final yield units when preparations are fully packaged using an automated compounding device, allow certain temperature exceptions for radiopharmaceutical compounding, and add specific requirements for records and recall procedures.

Why it matters: The changes affect pharmacies that compound sterile preparations used in hospitals, clinics and outpatient care. Several compounding operators told the board that expanded testing and preliminary validation could impose large compliance costs on small and mid‑size pharmacies and potentially reduce access…